AtriCure Inc (ATRC) - Product Pipeline Analysis, 2025 Update
Description
Summary
AtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atrial fibrillation (Afib) and related conditions. The company's primary activities involve the development and distribution of medical devices used by electrophysiologists and cardiothoracic surgeons. AtriCure's major products include the Isolator Synergy ablation system, AtriClip left atrial appendage exclusion system, hybrid AF therapy, and cryoICE cryoSPHERE probe. These products are used in various surgical procedures, including open-heart and minimally invasive surgeries, to treat Afib and manage post-operative pain. The company markets its products through various brands such as AtriCure, Coolrail, Isolator, Synergy, Flex-V, Lariat, Hybrid AF, cryosphere, cryoICE, AtriClip, COBRA, COBRA Fusion, Affirm, EPi-Sense, and olator. It operates in the US, Germany, France, the UK, the Benelux region, Canada, and Australia, among other locations. AtriCure Inc is headquartered in Mason, Ohio, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
AtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atrial fibrillation (Afib) and related conditions. The company's primary activities involve the development and distribution of medical devices used by electrophysiologists and cardiothoracic surgeons. AtriCure's major products include the Isolator Synergy ablation system, AtriClip left atrial appendage exclusion system, hybrid AF therapy, and cryoICE cryoSPHERE probe. These products are used in various surgical procedures, including open-heart and minimally invasive surgeries, to treat Afib and manage post-operative pain. The company markets its products through various brands such as AtriCure, Coolrail, Isolator, Synergy, Flex-V, Lariat, Hybrid AF, cryosphere, cryoICE, AtriClip, COBRA, COBRA Fusion, Affirm, EPi-Sense, and olator. It operates in the US, Germany, France, the UK, the Benelux region, Canada, and Australia, among other locations. AtriCure Inc is headquartered in Mason, Ohio, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AtriCure Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
36 Pages
- AtriCure Inc Company Overview
- AtriCure Inc Company Snapshot
- AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
- AtriCure Inc – Pipeline Analysis Overview
- Business Description
- AtriCure Inc - Key Facts
- AtriCure Inc - Major Products and Services
- AtriCure Inc Pipeline Products by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc Pipeline Products Overview
- AtriClip System - Stroke
- AtriClip System - Stroke Product Overview
- AtriClip System - Stroke Clinical Trial
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST)
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) Product Overview
- CryoICE Ablation System - Atrial Fibrillation
- CryoICE Ablation System - Atrial Fibrillation Product Overview
- CryoICE Ablation System - Atrial Fibrillation Clinical Trial
- cryoSPHERE Cryoablation Probe - Sternotomy
- cryoSPHERE Cryoablation Probe - Sternotomy Product Overview
- LARIAT Suture Delivery Device - Adjunctive Therapy
- LARIAT Suture Delivery Device - Adjunctive Therapy Product Overview
- Next Generation RF Generator
- Next Generation RF Generator Product Overview
- PFA Clamp
- PFA Clamp Product Overview
- AtriCure Inc - Key Competitors
- AtriCure Inc - Key Employees
- AtriCure Inc - Key Employee Biographies
- AtriCure Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- AtriCure Inc, Recent Developments
- Dec 11, 2025: AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
- Nov 18, 2025: AtriCure to Participate in Piper Sandler 37th Annual Healthcare Conference
- Oct 29, 2025: AtriCure treats first subject in BoxX-NoAF study
- Oct 28, 2025: AtriCure Announces First Patient Treated in BoxX-NoAF Clinical Trial
- Oct 27, 2025: AtriCure to Participate in Upcoming Investor Conferences
- Oct 08, 2025: AtriCure To Announce Third Quarter Financial Results
- Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
- Aug 04, 2025: AtriCure Receives Additional FDA 510(K) Clearance for Isolator Synergy Encompass Clamp
- Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
- Jul 15, 2025: AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
- AtriCure Inc Pipeline Products by Equipment Type
- AtriCure Inc Pipeline Products by Indication
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc, Key Facts
- AtriCure Inc, Major Products and Services
- AtriCure Inc Number of Pipeline Products by Development Stage
- AtriCure Inc Pipeline Products Summary by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc Ongoing Clinical Trials Summary
- AtriClip System - Stroke - Product Status
- AtriClip System - Stroke - Product Description
- AtriClip System - Stroke - Stand-alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion with AtriClip Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation - the Polish Nationwide Registry
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Status
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Description
- CryoICE Ablation System - Atrial Fibrillation - Product Status
- CryoICE Ablation System - Atrial Fibrillation - Product Description
- CryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
- CryoICE Ablation System - Atrial Fibrillation - Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain (VANISH)
- cryoSPHERE Cryoablation Probe - Sternotomy - Product Status
- cryoSPHERE Cryoablation Probe - Sternotomy - Product Description
- LARIAT Suture Delivery Device - Adjunctive Therapy - Product Status
- LARIAT Suture Delivery Device - Adjunctive Therapy - Product Description
- Next Generation RF Generator - Product Status
- Next Generation RF Generator - Product Description
- PFA Clamp - Product Status
- PFA Clamp - Product Description
- AtriCure Inc, Key Employees
- AtriCure Inc, Key Employee Biographies
- AtriCure Inc, Other Locations
- AtriCure Inc, Subsidiaries
- Glossary
- List of Figures
- AtriCure Inc Pipeline Products by Equipment Type
- AtriCure Inc Pipeline Products by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.